For-profit stem cell clinic secrets are bad news for patients. Stem cell clinics are in the business of making profits above all else and to make steady money they need a strong flow of patients as their paying customers for their non-FDA approved offerings. In order to keep the money pouring in, some of the […]
Shh! 10 stem cell clinic secrets kept from patients Read More »
Bulls-eye! Here are some stem cell weekend reads including both interesting new papers & news headlines. Of course, this week also had stem cell awareness day and I wrote about 10 key issues for the field for the coming 10 years! Weekend reads Papers Chromatin and Single-Cell RNA-Seq Profiling Reveal Dynamic Signaling and Metabolic Transitions during
TGIF stem cell weekend reads of papers & news Read More »
It’s stem cell day! Or more accurately, it is stem cell awareness day. It’s a good time to think about where our field stands and where we’ll be in 10 years. Below, I’ve outlined 10 for 10: 10 things to ponder about stem cells in a 10-year timeframe. Approved Therapies. How many new stem cell
10 for 10 on stem cell day: 10 issues for coming 10 years Read More »
What does the wide stem cell and regenerative medicine community think of California’s new stem cell law requiring that clinics selling non-FDA approved stem cell offerings make specific disclosures to prospective customers and that the state medical board keep track of how this all unfolds? You probably already know that I am supportive of the
Reactions to California’s new stem cell law on non-FDA approved clinic offerings Read More »
Two new FDA inspection reports called 483s provide fresh insights on a stem cell clinic, the network of clinics that it belongs to, and adverse events in patients. These reports detail issues the FDA found at the stem cell clinic California Stem Cell Treatment Center and its parent chain of clinics, Cell Surgical Network. The
New FDA Inspection 483s: Insights on Stem Cell Clinic & Cell Surgical Network Read More »
Right now the FDA has a big fat stem cell conundrum on its hands. The agency is faced with a tough dilemma as how to deal with fat (adipose) stem cell products and the large number of businesses who sell them. Are fat/adipose stem cells a drug or not? If yes, what does the FDA do
Dissecting the FDA’s big, fat stem cell dilemma Read More »
Sacramento’s Nervana stem cell clinic has been selling non-FDA approved stem cell therapies to patients for a variety of conditions including arthritis, pain, and neuropathy for a while now since last year, but in my opinion there isn’t good evidence to back up using amniotic or fat stem cells for such conditions. Further, my understanding
Customers rate Nervana stem cell clinic harshly on Yelp Read More »
Here is our listing of 2018 Stem Cell Meetings & Conferences. Send me your listings if you don’t see your meeting here. Meeting listings are not endorsements and I try to make this list fairly comprehensive. January World Stem Cell Summit, Miami, FL USA, January 22-26, 2018. 51st Miami Winter Symposium Stem Cells – Today’s
2018 Stem Cell Meetings & Conferences Read More »
Stem cell therapy cost is a moving target. A lot depends on the circumstances. Did you get the therapy at a university or major medical center or like most people these days at a stem cell clinic? Did insurance pay any of the cost and if so, how much? If not, how did you get
Stem cell therapy cost: if you got a treatment, how much did you pay? Read More »
On one level a reasonable argument can be made for letting terminally ill patients have a right to try experimental as yet unproven therapies, but in the real world Right-To-Try laws have many downsides. On the whole, they are likely to be negative for patients as a group. Raising the stakes is a push for
Will Right-To-Try Morph into Right-To-Profit for Stem Cell Clinics? Read More »